Page 24 - Central Drug Authority Annual Report 2021
P. 24

3. CDA SECRETARIAT

            7KH  $FW  SURYLGHV  IRU  WKH  HVWDEOLVKPHQW  RI  WKH  &'$   1R ([HFXWLYH 'LUHFWRU RI WKH &'$ DV SURYLGHG IRU LQ WKH
            VHFUHWDULDW  ZKLFK DFFRXQWV WR WKH &'$ DQG LV ORFDWHG LQ   $FW  KDV EHHQ DSSRLQWHG VLQFH WKH LQFHSWLRQ RI WKH &'$
            WKH  'HSDUWPHQW  RI  6RFLDO  'HSDUWPHQW   WKH  OHDG   7KH FDSDFLW\ RI WKH 6HFUHWDULDW LQ WKHUHIRUH QRW RSWLPDO
            GHSDUWPHQW LQ WKH ˉHOG RI VXEVWDQFH DEXVH  $Q LPSRUWDQW   7KH 6HFUHWDULDW LV IXOO\ DFFRXQWDEOH WR WKH GHSDUWPHQW
            IXQFWLRQ RI WKH &'$ LV WR PRQLWRU WKH LPSOHPHQWDWLRQ RI   UDWKHU WKDQ WKH &'$  7KLV SRVLWLRQLQJ RI WKH &'$ DQG LWV
            WKH  1'03   WR  IDFLOLWDWH  DQG  SURPRWH  DQ  LQWHJUDWHG   VHFUHWDULDW  ZKLFK LQ HIIHFW DQG LQ SUDFWLFH  KDV EHFRPH
            DSSURDFK  WR  VHUYLFH  GHOLYHU\   DQG  WR  FRRUGLQDWH   VXEVHUYLHQW  WR  WKH  'LUHFWRUDWH  RI  WKH  GHSDUWPHQW   KDG
            SURJUDPPHV  DLPHG  DW  WKH  FRQWURO  RI  VXEVWDQFHV  IRU   DQG  FRQWLQXHV  WR  KDYH  D  QHJDWLYH  HIIHFW  RQ  WKH
            PHGLFDO DQG VFLHQWLˉF XVH  LQ DOO VSKHUHV RI JRYHUQPHQW   IXQFWLRQLQJ  RI  WKH  &'$     6HYHUDO  VWXGLHV  DQG
            DQG  FLYLO  VRFLHW\   7KH  &'$  WKHUHIRUH  IDFLOLWDWHV   LQYHVWLJDWLRQV KDYH EHHQ GRQH  ZKLFK SURSRVH FRQFUHWH
            FRRSHUDWLRQ  EHWZHHQ  JRYHUQPHQW  DQG  VWDNHKROGHUV  LQ   PHDVXUHV IRU WKH VWUHQJWKHQLQJ RI WKH 6HFUHWDULDW  EXW
            WKH ˉHOG RI VXEVWDQFHV  LQFOXGLQJ WKH XVH DQG DEXVH RI   WKLV KDV QRW EHHQ HIIHFWHG   7KLV ZLOO QHHG WR EH RQH RI
            VXEVWDQFHV   DQG  WKH  PDQDJHPHQW  RI  OLFLW  DQG  LOOLFLW   WKH  NH\  SULRULWLHV  RI  WKH   WK  &'$   ZKLFK  ZLOO  EH
            VXEVWDQFHV                                       LQDXJXUDWHG LQ WKH QH[W ˉQDQFLDO \HDU


            7KH &'$ 6HFUHWDULDW WKXV SHUIRUPV WKH ZRUN LQFLGHQWDO WR
            WKH  IXQFWLRQV  RI  WKH  &'$  DQG  SURYLGHV  DGPLQLVWUDWLYH
            DQG RWKHU VXSSRUW DV PD\ EH UHTXLUHG E\ WKH &'$  7KH
            6HFUHWDULDW PXVW HQVXUH WKDW WKH GD\ WR GD\ ZRUN RI WKH
            &'$ LV FDUULHG RXW LQ OLQH ZLWK WKH UHTXLUHPHQWV RI WKH
            $FW  DQG  WKH  1'03   7KH  6HFUHWDULDW  DOVR  SURYLGHV
            WHFKQLFDO DQG DGPLQLVWUDWLYH VXSSRUW WR WKH &'$ DQG LWV
            LQVWLWXWLRQDO VXSSRUW VWUXFWXUHV  7KH FDSDFLWDWLRQ RI WKH
            &'$ VHFUHWDULDW LV FULWLFDO WR WKH &'$ GHOLYHULQJ RQ LWV
            PDQGDWH



            4.   COMPOSITION AND MEMBERSHIP OF THE CDA

             7KH 3UHYHQWLRQ RI DQG 7UHDWPHQW IRU 6XEVWDQFH $EXVH   0HPEHUV IURP WKH SULYDWH VHFWRU ZHUH QRPLQDWHG DQG
             $FW        $FW    RI       DQG WKH 1'03             WKHQ  VHOHFWHG  E\  WKH  3RUWIROLR  &RPPLWWHH  RQ  6RFLDO
             SUHVFULEHV WKDW WKH &'$ EH FRPSRVHG RI    PHPEHUV    'HYHORSPHQW  DQG  WKH  6HOHFW  &RPPLWWHH  RQ  6RFLDO
                 UHSUHVHQWDWLYHV  RI  WKH  GHVLJQDWHG  JRYHUQPHQW   6HUYLFHV    5HSUHVHQWDWLYHV   IURP   JRYHUQPHQW
             GHSDUWPHQWV DQG    GUXJ H[SHUWV  +RZHYHU  LQ WKH \HDU   GHSDUWPHQWV  ZHUH  QRPLQDWHG  E\  WKHLU  UHVSHFWLYH
             XQGHU UHYLHZ WKH &'$ KDG    PHPEHUV  FRQVLVWLQJ RI      PLQLVWHUV  DQG  DSSRLQWHG  E\  WKH  0LQLVWHU  RI  6RFLDO
             GHSDUWPHQWDO UHSUHVHQWDWLYHV DQG   GUXJ H[SHUWV  7KLV   'HYHORSPHQW DV VWLSXODWHG E\ OHJLVODWLRQ
             ZDV  GXH  WR  WKH  IDFW  WKDW  VRPH  GHSDUWPHQWV  KDG  QRW   .
             QRPLQDWHG  UHSUHVHQWDWLYHV   VRPH  KDG  PHUJHG  DQG
             VRPH  KDG  QRW  ˉOOHG  YDFDQFLHV   6RPH  GUXJ  H[SHUWV
             UHVLJQHG  SDVVHG RQ RU DEVFRQGHG


























     22                                Annual Report 2020/2021 Central Drug Authority
   19   20   21   22   23   24   25   26   27   28   29